Marianne P. Allen

Array ( [id] => 3790136 [patent_doc_number] => 05780245 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Polypeptides having a serotonin receptor activity, nucleic acids coding for these polypeptides and uses' [patent_app_type] => 1 [patent_app_number] => 8/416788 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5895 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780245.pdf [firstpage_image] =>[orig_patent_app_number] => 416788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3504283 [patent_doc_number] => 05514566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Methods of producing recombinant fibroblast growth factors' [patent_app_type] => 1 [patent_app_number] => 8/417022 [patent_app_country] => US [patent_app_date] => 1995-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 10349 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514566.pdf [firstpage_image] =>[orig_patent_app_number] => 417022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1275682 [patent_doc_number] => 06645498 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Soluble variants of type I membrane proteins, and methods of using them' [patent_app_type] => B1 [patent_app_number] => 08/413805 [patent_app_country] => US [patent_app_date] => 1995-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10491 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645498.pdf [firstpage_image] =>[orig_patent_app_number] => 08413805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807702 [patent_doc_number] => 05854217 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function' [patent_app_type] => 1 [patent_app_number] => 8/413490 [patent_app_country] => US [patent_app_date] => 1995-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 23 [patent_no_of_words] => 26293 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854217.pdf [firstpage_image] =>[orig_patent_app_number] => 413490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770477 [patent_doc_number] => 05807691 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Polypeptides having serotonin receptor activity (5HT5A), nucleic acids coding for these polypeptides and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/356405 [patent_app_country] => US [patent_app_date] => 1995-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5844 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807691.pdf [firstpage_image] =>[orig_patent_app_number] => 356405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975382 [patent_doc_number] => 05916871 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Inhibitory factor' [patent_app_type] => 1 [patent_app_number] => 8/411396 [patent_app_country] => US [patent_app_date] => 1995-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 24155 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916871.pdf [firstpage_image] =>[orig_patent_app_number] => 411396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4358066 [patent_doc_number] => 06168946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'gp75 as a tumor vaccine for melanoma' [patent_app_type] => 1 [patent_app_number] => 8/409794 [patent_app_country] => US [patent_app_date] => 1995-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 10084 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/168/06168946.pdf [firstpage_image] =>[orig_patent_app_number] => 409794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657495 [patent_doc_number] => 05658883 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Biologically active TGF-.beta.1 peptides' [patent_app_type] => 1 [patent_app_number] => 8/400607 [patent_app_country] => US [patent_app_date] => 1995-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6932 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658883.pdf [firstpage_image] =>[orig_patent_app_number] => 400607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3608604 [patent_doc_number] => 05589456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Granulocyte-colony stimulating factor receptors' [patent_app_type] => 1 [patent_app_number] => 8/382771 [patent_app_country] => US [patent_app_date] => 1995-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9597 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589456.pdf [firstpage_image] =>[orig_patent_app_number] => 382771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158225 [patent_doc_number] => 06107472 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Receptor-type tyrosine kinase-like molecules' [patent_app_type] => 1 [patent_app_number] => 8/335865 [patent_app_country] => US [patent_app_date] => 1995-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 14 [patent_no_of_words] => 19874 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107472.pdf [firstpage_image] =>[orig_patent_app_number] => 335865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589165 [patent_doc_number] => 05567611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => 'Multifunctional M-CSF proteins and genes encoding therefor' [patent_app_type] => 1 [patent_app_number] => 8/354456 [patent_app_country] => US [patent_app_date] => 1994-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19490 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567611.pdf [firstpage_image] =>[orig_patent_app_number] => 354456 [rel_patent_id] =>[rel_patent_doc_number] =>)